Nevro Corp (NVRO):企業の財務・戦略的SWOT分析

◆英語タイトル:Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14458
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nevro Corp (Nevro) is a medical device company which focuses on providing novel products that advance the quality of life of people suffering from chronic pain. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Nevro Senza SCS system is commercially available in the US, Europe and Australia. The company offers products under Senza, Senza II, HF10, Nevro and the Nevro logo brands. Nevro is developing HF10 therapy for treating painful diabetic neuropathy and non-surgical refractory back pain. Nevro is headquartered in Redwood City, California, the US.

Nevro Corp Key Recent Developments

Feb 21,2019: Nevro reports fourth quarter and full year 2018 financial results
Feb 21,2019: Stimwave addresses patent infringement lawsuit brought by Nevro
Jan 07,2019: Nevro announces preliminary unaudited fourth quarter and full year 2018 revenue
Nov 05,2018: Nevro Reports Third Quarter 2018 Financial Results

This comprehensive SWOT profile of Nevro Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nevro Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Nevro Corp – Key Information
Nevro Corp – Overview
Nevro Corp – Key Employees
Nevro Corp – Key Employee Biographies
Nevro Corp – Key Operational Heads
Nevro Corp – Major Products and Services
Nevro Corp – History
Nevro Corp – Company Statement
Nevro Corp – Locations And Subsidiaries
Nevro Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Nevro Corp – Business Description
Nevro Corp – Corporate Strategy
Nevro Corp – SWOT Analysis
SWOT Analysis – Overview
Nevro Corp – Strengths
Nevro Corp – Weaknesses
Nevro Corp – Opportunities
Nevro Corp – Threats
Nevro Corp – Key Competitors

Section 3 – Company Financial Performance Charts

Nevro Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Nevro Corp, Key Information
Nevro Corp, Key Ratios
Nevro Corp, Share Data
Nevro Corp, Major Products and Services
Nevro Corp, History
Nevro Corp, Key Employees
Nevro Corp, Key Employee Biographies
Nevro Corp, Key Operational Heads
Nevro Corp, Other Locations
Nevro Corp, Subsidiaries
Nevro Corp, Key Manufacturing facilities
Nevro Corp, Key Competitors
Nevro Corp, SWOT Analysis
Nevro Corp, Ratios based on current share price
Nevro Corp, Annual Ratios
Nevro Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Nevro Corp, Performance Chart
Nevro Corp, Ratio Charts

★海外企業調査レポート[Nevro Corp (NVRO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pakistan International Airlines Corporation
    Pakistan International Airlines Corporation - Strategy, SWOT and Corporate Finance Report Summary Pakistan International Airlines Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Cantargia AB (CANTA):企業の財務・戦略的SWOT分析
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of cancers including non-small cell lung cancer and pancreatic cancer. It utilize …
  • SM Energy Company:企業の戦略・SWOT・財務情報
    SM Energy Company - Strategy, SWOT and Corporate Finance Report Summary SM Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • University of Tennessee Research Foundation-製薬・医療分野:企業M&A・提携分析
    Summary University of Tennessee Research Foundation (UTRF), a subsidiary of University of Tennessee is a non profit organization that promotes research and education. The organization offers agriculture, chemistry and materials; energy, animal health, engineering, human health, research tools and so …
  • Cara Therapeutics Inc (CARA):企業の財務・戦略的SWOT分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruritus. Its lead product candidate includes …
  • Marubeni Corporation:企業の戦略・SWOT・財務分析
    Marubeni Corporation - Strategy, SWOT and Corporate Finance Report Summary Marubeni Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析
    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Bio Techne Corp (TECH)-製薬・医療分野:企業M&A・提携分析
    Summary Bio Techne Corp (Bio Techne), develops manufactures and sells biotechnology products and instruments for research and clinical diagnostics. The company provides proteins and antibodies, and related immunoassays and other reagents for research under brands such as R&D Systems, Novus, Biologic …
  • Zoomlion Heavy Industry Science and Technology Co., Ltd.:企業の戦略・SWOT・財務情報
    Zoomlion Heavy Industry Science and Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Zoomlion Heavy Industry Science and Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the comp …
  • Arch Therapeutics Inc (ARTH):医療機器:M&Aディール及び事業提携情報
    Summary Arch Therapeutics Inc (Arch Therapeutics) is a medical device company that develops self-assembling barrier technologies to improve interventional wound care outcomes. The company offers hemostasis and sealant products to seal and protect leaking and bleeding tissue. It provides intervention …
  • Lantronix, Inc. (LTRX):企業の財務・戦略的SWOT分析
    Lantronix, Inc. (LTRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • ZAD Bulstrad Vienna Insurance Group:企業の戦略・SWOT・財務分析
    ZAD Bulstrad Vienna Insurance Group - Strategy, SWOT and Corporate Finance Report Summary ZAD Bulstrad Vienna Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Iovance Biotherapeutics Inc (IOVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Iovance Biotherapeutics Inc (Iovance), formerly Lion Biotechnologies Inc is a biotechnology company that focuses on developing novel cancer immunotherapy products for treating various cancers. It develops products based on tumor-infiltrating lymphocyte (TIL) technology. The company’s lead pr …
  • ArcelorMittal:企業の戦略・SWOT・財務情報
    ArcelorMittal - Strategy, SWOT and Corporate Finance Report Summary ArcelorMittal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Compuware Corp:企業の戦略・SWOT・財務分析
    Compuware Corp - Strategy, SWOT and Corporate Finance Report Summary Compuware Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Rockwell Medical Inc (RMTI)-製薬・医療分野:企業M&A・提携分析
    Summary Rockwell Medical Inc (Rockwell) is a bio pharmaceutical company focusing on the development, manufacture and distribution of products and services for the treatment of iron deficiency, secondary hyperparathyroidism; end-stage renal disease (ESRD) and chronic kidney disease. Its major product …
  • Port of Rotterdam Authority NV:企業の戦略的SWOT分析
    Port of Rotterdam Authority NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Alitalia – Societa Aerea Italiana S.p.A.:戦略・SWOT・企業財務分析
    Alitalia - Societa Aerea Italiana S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Alitalia - Societa Aerea Italiana S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Emerald Health Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Emerald Health Sciences Inc (EHS) focuses to advance the development of cannabis in pharmaceutical, botanical and bioceutical applications. The company is developing EHP-101 based on cannabidiol for the treatment of multiple sclerosis (MS) and scleroderma; and EHP-102, derived from cannabige …
  • Aldi Einkauf GmbH & Co oHG:戦略・SWOT・企業財務分析
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆